Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Allerid-C
Active Ingredient: Cetirizine hydrochloride 1mg/mL
Dosage Form: Syrup
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Mediorals Laboratories Pvt Limited, Satara, Maharashtra, India
Product: Pegasys
Active Ingredient: Peginterferon alfa-2a (40KD) 135Ág/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer: F Hoffmann-La Roche Limited, Basel, Switzerland
Product: Pegasys
Active Ingredient: Peginterferon alfa-2a (40KD) 270Ág/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer: F Hoffmann-La Roche Limited, Basel, Switzerland
Product: Pegasys
Active Ingredient: Peginterferon alfa-2a (40KD) 180Ág/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer: F Hoffmann-La Roche Limited, Basel, Switzerland
Product: Pegasys
Active Ingredient: Peginterferon alfa-2a (40KD) 360Ág/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer: F Hoffmann-La Roche Limited, Basel, Switzerland
Dated this 31st day of January 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).